Dynamic contrast-enhanced magnetic resonance imaging of tumors: Preclinical validation of parametric images

Radiation Research

Volumn 172, Issue 3, 2009, Pages 339-347

  Egeland, Tormod A M ^a   Simonsen, Trude G ^a   Gaustad, Jon Vidar ^a   Gulliksrud, Kristine ^a   Ellingsen, Christine ^a   Rofstad, Einar K ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

GADOLINIUM PENTETATE; RUBIDIUM 86; CONTRAST MEDIUM; DIAGNOSTIC AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; EXTRACELLULAR SPACE; FEMALE; IMAGE ANALYSIS; MELANOMA CELL; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; TUMOR VOLUME; ALGORITHM; ANIMAL; BAGG ALBINO MOUSE; BIOLOGICAL MODEL; COMPUTER ASSISTED DIAGNOSIS; COMPUTER SIMULATION; EVALUATION; IMAGE ENHANCEMENT; MELANOMA; METABOLISM; METHODOLOGY; PATHOLOGY; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; TUMOR CELL LINE;

ALGORITHMS; ANIMALS; CELL LINE, TUMOR; COMPUTER SIMULATION; CONTRAST MEDIA; FEMALE; GADOLINIUM DTPA; IMAGE ENHANCEMENT; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MELANOMA; MICE; MICE, INBRED BALB C; MODELS, BIOLOGICAL; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 70349911870     PISSN: 00337587     EISSN: None     Source Type: Journal    
DOI: 10.1667/RR1787.1     Document Type: Article

References (35)

1. J. M. Brown and A. J. Giaccia, The unique physiology of solid tumors: opportunities (and problems) for cancer therapy. Cancer Res. 58, 1408-1416 (1998).
2. R. Cairns, I. Papandreou and N. Denko, Overcoming physiologic barriers to cancer treatment by molecularly targeting the tumor microenvironment. Mol. Cancer Res. 4, 61-70 (2006).
3. M. Höckel and P. Vaupel, Tumor hypoxia: definitions and current clinical, biologic, and molecular aspects. J. Natl. Cancer Inst. 93, 266-276 (2001).
4. E. K. Rofstad, Microenvironment-induced cancer metastasis. Int. J. Radiat. Biol. 76, 589-605 (2000).
5. C. J. Gulledge and M. W. Dewhirst, Tumor oxygenation: a matter of supply and demand. Anticancer Res. 16, 741-750 (1996).
6. N. Hylton, Dynamic contrast-enhanced magnetic resonance imaging as an imaging biomarker. J. Clin. Oncol. 24, 3293-3298 (2006).
7. M. A. Zahra, K. G. Hollingsworth, E. Sala, D. J. Lomas and L. T. Tan, Dynamic contrast-enhanced MRI as a predictor of tumour response to radiotherapy. Lancet Oncol. 8, 63-74 (2007).
8. I. Ocak, P. Baluk, T. Barrett, D. M. McDonald and P. Choyke, The biologic basis of in vivo angiogenesis imaging. Front. Biosci. 12, 3601-3616 (2007).
9. D. Jennings, N. Raghunand and R. J. Gillies, Imaging hemodynamics. Cancer Metastasis Rev. 27, 589-613 (2008).
10. S. S. Kety, Theory of blood-tissue exchange and its application to measurements of blood flow. Methods Med. Res. 8, 228-236 (1960).
11. 1-weighted MRI of a diffusable tracer: standardized quantities and symbols. J. Magn. Reson. Imaging 10, 223-232 (1999).
12. T. E. Yankeelov, W. D. Rooney, X. Li and C. S. Springer, Variation of the relaxographic "shutter-speed" for transcytolem-mal water exchange affects the CR bolus-tracking curve shape. Magn. Reson. Med. 50, 1151-1169 (2003).
13. A. Z. Faranesh and T. E. Yankeelov, Incorporating a vascular term into a reference region model for the analysis of DCE-MRI data: a simulation study. Phys. Med. Biol. 53, 2617-2631 (2008).
14. M. O. Leach, K. M. Brindle, J. L. Evelhoch, J. R. Griffiths, M. R. Horsman, A. Jackson, G. C. Jayson, I. R. Judson, M. V. Knopp and P. Workman, The assessment of antiangio-genic and antivascular therapies in early-stage clinical trials using magnetic resonance imaging: issues and recommendations. Br. J. Cancer 92, 1599-1610 (2005).
15. 15O-PET and DCE-MRI to measure tumor blood flow. Oncologist 13, 631-644 (2008).
16. E. K. Rofstad, Orthotopic human melanoma xenograft model systems for studies of tumour angiogenesis, pathophysiology, treatment sensitivity and metastatic pattern. Br. J. Cancer 70, 804-812 (1994).
17. E. K. Rofstad, K. Galappathi, B. Mathiesen and E. B. M. Ruud, Fluctuating and diffusion-limited hypoxia in hypoxia-induced metastasis. Clin. Cancer Res. 13, 1971-1978 (2007).
18. T. A. M. Egeland, J. V. Gaustad, I. C. Benjaminsen, K. Hedalen, B. Mathiesen and E. K. Rofstad, Assessment of fraction of hypoxic cells in human tumor xenografts with necrotic regions by dynamic contrast-enhanced MRI. Radiat. Res. 169, 689-699 (2008).
19. K. Hittmair, G. Gomiscek, K. Langenberger, M. Recht, H. Imhof and J. Kramer, Method for the quantitative assessment of contrast agent uptake in dynamic contrast-enhanced MRI. Magn. Reson. Med. 31, 567-571 (1994).
20. I. C. Benjaminsen, B. A. Graff, K. G. Brurberg and E. K. Rofstad, Assessment of tumor blood perfusion by high-resolution DCE-MRI: a preclinical study of human melanoma xenografts. Magn. Reson. Med. 52, 269-276 (2004).
21. I. Brammer and H. Jung, Morphometry of irradiated tumors. In Rodent Tumor Models for Experimental Cancer Therapy (A. F. Kallman, Ed.), pp. 97-100. Pergamon Press, Oxford, 1987.
22. L. K. Appelgren, Methods of recording tumor blood flow. In Tumor Blood Circulation: Angiogenesis, Vascular Morphology and Blood Flow of Experimental and Human Tumors (H. I. Peterson, Ed.), pp. 87-101. CRC Press, Boca Raton, FL, 1979.
23. 86Rb. Cancer Res. 34, 1451-1456 (1974).
24. H. M. Kaplan, N. R. Brewer and W. H. Blair, Physiology. In The Mouse in Biomedical Research (H. L. Foster, J. D. Small and J. G. Fox, Eds.), pp. 247-292. Academic Press, New York, 1983.
25. K. G. Brurberg, I. C. Benjaminsen, L. M. R. Dørum and E. K. Rofstad, Fluctuations in tumor blood perfusion assessed by dynamic-contrast enhanced MRI. Magn. Reson. Med. 58, 473-481 (2007).
26. J. V. Gaustad, I. C. Benjaminsen, B. A. Graff, K. G. Brurberg, E. B. Ruud and E. K. Rofstad, Intratumor heterogeneity in blood perfusion in orthotopic human melanoma xenografts assessed by dynamic contrast-enhanced magnetic resonance imaging. J. Magn. Reson. Imaging 21, 792-800 (2005).
27. T. A. Egeland, J. V. Gaustad, I. K. Vestvik, I. C. Benjaminsen, B. Mathiesen and E. K. Rofstad, Assessment of fraction of radiobiologically hypoxic cells in human melanoma xenografts by dynamic contrast-enhanced MRI. Magn. Reson. Med. 55, 874-882 (2006).
28. B. A. Graff, I. C. Benjaminsen, K. G. Brurberg, E. B. Ruud and E. K. Rofstad, Comparison of tumor blood perfusion assessed by dynamic contrast-enhanced MRI with tumor blood supply assessed by invasive imaging. J. Magn. Reson. Imaging 21, 272-281 (2005).
29. I. C. Benjaminsen, K. G. Brurberg, E. B. Ruud and E. K. Rofstad, Assessment of extravascular extracellular space fraction in human melanoma xenografts by DCE-MRI and kinetic modeling. Magn. Reson. Imaging 26, 160-170 (2008).
30. B. A. Graff, Y. Kvinnsland, A. Skretting and E. K. Rofstad, Intratumour heterogeneity in the uptake of macromolecular therapeutic agents in human melanoma xenografts. Br. J. Cancer 88, 291-297 (2003).
31. I. Bjørnæs and E. K. Rofstad, Microvascular permeability to macromolecules in human melanoma xenografts assessed by contrast-enhanced MRI - intertumor and intratumor heterogeneity. Magn. Reson. Imaging 19, 723-730 (2001).
32. B. A. Graff, L. Vangberg and E. K. Rofstad, Quantitative assessment of uptake and distribution of iron oxide particles (NC100150) in human melanoma xenografts by contrast-enhanced MRI. Magn. Reson. Med. 51, 727-735 (2004).
33. P. M. Gullino, Extracellular compartments of solid tumors. In Cancer: A Comprehensive Treatise, Vol. 3 (F. F. Becker, Ed.), pp. 327-354. Plenum Press, New York, 1975.
34. J. L. Bert and R. H. Pearce, The interstitium and microvascular exchange. In Handbook of Physiology: The Cardiovascular System, Vol. IV (E. M. Renkin and and C. C. Michel, Eds.), pp. 521-547. American Physiological Society, Bethesda, MD, 1984.
35. R. K. Jain, Transport of molecules in the tumor interstitium: a review. Cancer Res. 47, 3039-3051 (1987).